MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 104 filers reported holding MERUS N V in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $10,108,839 | +118.2% | 170,844 | +66.1% | 0.01% | +100.0% |
| Q1 2024 | $4,632,912 | +168.2% | 102,885 | +63.8% | 0.00% | +100.0% |
| Q4 2023 | $1,727,688 | +174.8% | 62,825 | +135.6% | 0.00% | +100.0% |
| Q3 2023 | $628,761 | -15.1% | 26,665 | -5.2% | 0.00% | 0.0% |
| Q2 2023 | $740,347 | +5374.3% | 28,118 | +3725.6% | 0.00% | – |
| Q1 2023 | $13,524 | -14.7% | 735 | -28.3% | 0.00% | – |
| Q4 2022 | $15,857 | -99.9% | 1,025 | -23.0% | 0.00% | – |
| Q3 2022 | $26,660,000 | -35.0% | 1,331 | -26.5% | 0.00% | – |
| Q2 2022 | $41,001,000 | +77.6% | 1,811 | +107.4% | 0.00% | – |
| Q1 2022 | $23,082,000 | +3721.5% | 873 | +4494.7% | 0.00% | – |
| Q4 2021 | $604,000 | -92.5% | 19 | -94.8% | 0.00% | – |
| Q3 2021 | $8,074,000 | +3.3% | 367 | -1.1% | 0.00% | – |
| Q2 2021 | $7,817,000 | +107.9% | 371 | +106.1% | 0.00% | – |
| Q1 2021 | $3,760,000 | – | 180 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 1,152,525 | $30,345,983 | 19.88% |
| COMMODORE CAPITAL LP | 4,000,000 | $105,320,000 | 11.84% |
| Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $42,128,000 | 11.80% |
| Aquilo Capital Management, LLC | 775,109 | $20,408,620 | 11.31% |
| VR Adviser, LLC | 1,726,214 | $45,451,215 | 7.27% |
| Ally Bridge Group (NY) LLC | 199,221 | $5,245,489 | 6.35% |
| Fairmount Funds Management LLC | 1,482,405 | $39,031,724 | 5.50% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 589,255 | $15,515,084 | 4.80% |
| DAFNA Capital Management LLC | 384,870 | $10,133,627 | 2.77% |
| Nan Fung Group Holdings Ltd | 151,000 | $3,975,830 | 2.54% |